AI-assisted, human-published
10/03/2025 /Funding Events
Cirrus Secures Seed Funding to Develop Breakthrough Ocular Gene Therapy
Cirrus raises seed funding to advance a novel adeno-associated virus (AAV) ocular gene therapy targeting the underlying cause of dry age-related macular degeneration.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com